← Open Payments lookup

LETHA SUNIL: Open Payments

NPI 1053952531 · OLNEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,399 in 64 payments from 8 companies in 2025. Trend: 2023 $179 · 2024 $583 · 2025 $1,399

Food & beverage: $1,391Education: $8
CompanyPaymentsAmount
ABBVIE INC.26$574
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$221
Takeda Pharmaceuticals U.S.A., Inc.13$180
Lundbeck LLC6$150
Otsuka America Pharmaceutical, Inc.7$145
Neurocrine BioSciences, Inc.3$65
Supernus Pharmaceuticals, Inc.3$48
Teva Pharmaceuticals USA, Inc.1$14

Products named: VRAYLAR, REXULTI, CAPLYTA, TRINTELLIX, INGREZZA, Qelbree, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.